jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Advanced King (Male) Full Body

Full Body

102 parameters

image

Report in 24Hrs

image

At Home

fastingrequire

Fasting Required

Details

Advanced Health covering Blood, Diabetes, Heart, Liver, Kidney, Thyroid, Iron, Sugar, Inflamation, Bone, Vitamins, Urine, Cancer Marker, Pancreas, Cardiac Marker, Arthritis

₹4,660₹7,999

42% OFF

Parameters

  • List of Tests
    • Sugar (Glucose) Fasting
    • CBC - Complete Hemogram
    • Liver Function Test
      • Albumin
      • Alkaline Phosphatase
      • Bilirubin - Direct
      • Bilirubin - Indirect
      • Bilirubin - Total
      • AST/SGOT
      • ALT/SGPT
      • Total Protein
      • A/G Ratio
      • Gamma GT
      • Globulin
    • Kidney Profile
      • BUN
      • Calcium
      • Creatinine
      • Uric Acid
      • eGFR
      • BUN/Creatinine
      • Urea
      • Sodium
      • Potassium
      • Chloride
    • Lipid Profile
      • Cholestrol/HDL
      • LDL/HDL
      • Non HDL
      • VLDL
      • Total Cholestrol
      • Triglycerides
      • HDL
      • LDL
    • Iron Studies
      • Iron
      • TIBC
      • Transferrin Saturation
    • Thyroid Profile
      • Total T3
      • Total T4
      • TSH
    • Hba1c
    • eAG
    • ESR
    • hs-CRP
    • Vitamin B12
    • 25 OH Vitamin D
    • Urine Complete
    • RF
    • Phosphorous
    • Amylase
    • Lipase
    • Total IgE
    • Carcino Embryonic Antigen (CEA)

Super Advanced Wellness Package - King

  • Why is it done?
    • Comprehensive health screening to assess overall metabolic, endocrine, hepatic, renal, and hematologic status for disease prevention and early detection
    • Evaluate glucose metabolism and diabetes risk through fasting glucose and HbA1c testing, allowing early intervention in prediabetic states
    • Assess cardiovascular risk factors through lipid profile analysis (total cholesterol, LDL, HDL, triglycerides, VLDL, non-HDL cholesterol)
    • Screen for liver dysfunction through comprehensive hepatic function markers including bilirubin, transaminases (AST/ALT), alkaline phosphatase, and proteins
    • Evaluate renal function and electrolyte balance through kidney profile including creatinine, BUN, eGFR, and electrolytes (sodium, potassium, chloride)
    • Assess complete blood count for anemia, infection, and hematologic disorders through hemoglobin, hematocrit, RBC, WBC, and platelet analysis
    • Evaluate thyroid function and metabolism through TSH, Total T3, and Total T4 measurements, detecting hypothyroidism and hyperthyroidism
    • Screen for inflammatory conditions through ESR and high-sensitivity CRP, markers of systemic inflammation and cardiovascular risk
    • Assess iron metabolism and detect anemia etiology through iron, TIBC, and transferrin saturation measurements
    • Evaluate vitamin deficiencies through B12 and 25-OH Vitamin D testing, which affect energy metabolism and bone health respectively
    • Screen for pancreatic disease and disorders through amylase and lipase measurements, detecting pancreatitis or pancreatic insufficiency
    • Assess bone metabolism and calcium regulation through phosphorus and calcium measurements
    • Screen for autoimmune conditions and rheumatologic diseases through Rheumatoid Factor (RF) testing
    • Evaluate immune response and allergic conditions through total IgE measurement
    • Screen for urinary tract abnormalities and kidney disease through comprehensive urinalysis including protein, glucose, cells, and casts
    • Screen for malignancy risk through Carcinoembryonic Antigen (CEA), a tumor marker useful for baseline assessment and cancer surveillance
    • Recommended for comprehensive annual health check-ups, executive health screening, baseline assessment, and monitoring of chronic disease management
  • Normal Range
    • Sugar (Glucose) Fasting: 70-100 mg/dL (3.9-5.6 mmol/L) - Normal fasting glucose; 100-125 mg/dL indicates impaired fasting glucose; >126 mg/dL suggests diabetes
    • Hemoglobin (Male): 13.5-17.5 g/dL; (Female): 12.0-15.5 g/dL - Lower levels indicate anemia; elevated levels suggest polycythemia
    • Hematocrit (Male): 41-53%; (Female): 36-46% - Percentage of red blood cells in blood volume
    • Red Blood Cell Count (Male): 4.7-6.1 million/μL; (Female): 4.2-5.4 million/μL - Counts below range indicate anemia
    • White Blood Cell Count: 4,500-11,000 cells/μL - Elevated counts suggest infection or leukemia; low counts indicate immunosuppression
    • Platelet Count: 150,000-400,000/μL - Low counts increase bleeding risk; elevated counts may indicate inflammation or thrombotic risk
    • Total Bilirubin: 0.1-1.2 mg/dL (1.7-20.5 μmol/L) - Elevated levels suggest jaundice or liver dysfunction
    • Direct Bilirubin: 0.0-0.3 mg/dL (0-5.1 μmol/L) - Indicates conjugated bilirubin; elevation suggests biliary obstruction
    • Indirect Bilirubin: 0.1-0.9 mg/dL (1.7-15.4 μmol/L) - Unconjugated bilirubin; elevation suggests hemolysis or liver uptake dysfunction
    • AST/SGOT: 10-40 U/L - Elevated in liver disease, myocardial infarction, and muscle injury
    • ALT/SGPT: 7-56 U/L - More specific for liver disease than AST; elevation indicates hepatic injury
    • Alkaline Phosphatase: 44-147 U/L - Elevated in bone disease, biliary obstruction, and pregnancy
    • Gamma GT: 9-48 U/L - Elevated in liver disease and with alcohol consumption
    • Total Protein: 6.0-8.3 g/dL - Reflects nutritional status and immune function
    • Albumin: 3.5-5.0 g/dL - Low levels indicate malnutrition, liver disease, or kidney disease
    • Globulin: 2.3-3.5 g/dL - Calculated as Total Protein minus Albumin; reflects immune proteins
    • A/G Ratio (Albumin/Globulin): 1.0-2.5 - Ratio below 1.0 suggests chronic liver disease or immune dysfunction
    • Creatinine: 0.7-1.3 mg/dL (62-115 μmol/L) - Marker of kidney function; elevation indicates renal impairment
    • BUN (Blood Urea Nitrogen): 7-20 mg/dL (2.5-7.1 mmol/L) - Elevated in renal disease or dehydration
    • BUN/Creatinine Ratio: 10:1 to 20:1 - Elevated ratio suggests pre-renal azotemia; low ratio may indicate liver disease
    • eGFR (Estimated Glomerular Filtration Rate): >60 mL/min/1.73m² - Normal kidney function; <60 indicates chronic kidney disease
    • Urea: 7-20 mg/dL (2.5-7.1 mmol/L) - Similar interpretation to BUN
    • Sodium: 135-145 mEq/L (135-145 mmol/L) - Critical for fluid balance and nerve function; abnormalities cause neurologic symptoms
    • Potassium: 3.5-5.0 mEq/L (3.5-5.0 mmol/L) - Essential for cardiac function; abnormalities cause arrhythmias
    • Chloride: 96-106 mEq/L (96-106 mmol/L) - Maintains acid-base balance and osmotic pressure
    • Calcium: 8.5-10.2 mg/dL (2.12-2.55 mmol/L) - Low levels cause tetany; high levels cause hypercalcemia symptoms
    • Phosphorus: 2.5-4.5 mg/dL (0.81-1.45 mmol/L) - Works with calcium for bone health; inverse relationship with PTH
    • Uric Acid (Male): 3.5-7.2 mg/dL; (Female): 2.6-6.0 mg/dL - Elevated levels increase gout risk and suggest purine metabolism dysfunction
    • Total Cholesterol: <200 mg/dL (<5.2 mmol/L) optimal - 200-239 mg/dL borderline; ≥240 mg/dL high risk
    • LDL Cholesterol: <100 mg/dL optimal; 100-129 mg/dL near optimal; 130-159 mg/dL borderline high; ≥160 mg/dL high
    • HDL Cholesterol (Male): >40 mg/dL; (Female): >50 mg/dL protective - Lower levels increase cardiovascular risk
    • Triglycerides: <150 mg/dL (<1.7 mmol/L) optimal - 150-199 mg/dL borderline high; ≥200 mg/dL high
    • VLDL: <30 mg/dL - Calculated from triglycerides; elevated with hypertriglyceridemia
    • Non-HDL Cholesterol: <130 mg/dL optimal - Better predictor of cardiovascular risk than LDL alone
    • Cholesterol/HDL Ratio: <5.0 optimal - Indicates cardiovascular risk; lower ratios are protective
    • LDL/HDL Ratio: <3.0 optimal - Another cardiovascular risk indicator; lower is better
    • Iron: 60-170 μg/dL (10.7-30.4 μmol/L) - Low levels suggest iron deficiency anemia; high levels indicate iron overload
    • TIBC (Total Iron-Binding Capacity): 250-425 μg/dL (45-76 μmol/L) - Elevated in iron deficiency; low in iron overload
    • Transferrin Saturation: 20-50% - Low levels (<20%) suggest iron deficiency; high levels (>50%) indicate iron overload
    • TSH (Thyroid Stimulating Hormone): 0.4-4.0 mIU/L - Elevated suggests primary hypothyroidism; low suggests hyperthyroidism
    • Total T3: 80-200 ng/dL (1.2-3.1 nmol/L) - Low in hypothyroidism and non-thyroid illness; elevated in hyperthyroidism
    • Total T4: 4.5-12 μg/dL (58-154 nmol/L) - Reflects thyroid hormone production; abnormalities indicate thyroid dysfunction
    • HbA1c: <5.7% optimal; 5.7-6.4% prediabetic range; ≥6.5% diagnostic of diabetes - Reflects average glucose over 3 months
    • eAG (Estimated Average Glucose): <117 mg/dL optimal; correlates with HbA1c percentage
    • ESR (Erythrocyte Sedimentation Rate) Male: <15 mm/hr; Female: <20 mm/hr - Elevated in inflammation, infection, and malignancy
    • hs-CRP (High-Sensitivity C-Reactive Protein): <3.0 mg/L - Elevated indicates inflammation and cardiovascular risk
    • Vitamin B12: 200-900 pg/mL (148-664 pmol/L) - Low levels cause pernicious anemia and neuropathy; deficiency at <200 pg/mL
    • 25-OH Vitamin D: 30-100 ng/mL (75-250 nmol/L) optimal - 20-29 ng/mL insufficient; <20 ng/mL deficient
    • Amylase: 30-110 U/L - Elevated in acute pancreatitis, salivary gland disorders, and some malignancies
    • Lipase: 0-60 U/L - More specific for pancreatic disease than amylase; elevated in pancreatitis
    • Total IgE: <100 IU/mL (0-200 kIU/L) - Elevated in allergic conditions and atopic diseases
    • Rheumatoid Factor (RF): Negative (<10 IU/mL) - Positive in rheumatoid arthritis but not diagnostic alone
    • CEA (Carcinoembryonic Antigen): <2.5 ng/mL smokers; <5 ng/mL non-smokers - Elevated in various malignancies and inflammatory conditions
    • Urine Complete: Normal findings include negative for protein, glucose, blood, ketones, bilirubin, nitrites, and leukocyte esterase; pH 4.5-8.0; specific gravity 1.005-1.030
  • Interpretation
    • Sugar (Glucose) Fasting: Elevated fasting glucose (>126 mg/dL on two occasions) confirms diabetes diagnosis; 100-125 mg/dL represents impaired fasting glucose requiring lifestyle intervention; values <100 mg/dL are normal
    • CBC Interpretation: Low hemoglobin indicates anemia; elevated WBC suggests infection, leukemia, or stress response; low WBC indicates bone marrow suppression or immunodeficiency; low platelets increase bleeding risk; elevated platelets suggest thrombotic tendency
    • Liver Function Tests: Elevated transaminases (AST/ALT) indicate hepatocellular injury from viral hepatitis, cirrhosis, or drug toxicity; elevated ALP suggests biliary obstruction or bone disease; elevated bilirubin indicates jaundice; abnormal A/G ratio suggests chronic liver disease
    • Kidney Profile: Elevated creatinine indicates renal impairment; eGFR <60 confirms chronic kidney disease; elevated potassium (hyperkalemia) risks cardiac arrhythmias requiring urgent treatment; elevated sodium (hypernatremia) causes dehydration; low sodium (hyponatremia) causes neurologic symptoms
    • Lipid Profile: Elevated LDL cholesterol increases atherosclerotic risk; low HDL worsens cardiovascular prognosis; elevated triglycerides increase pancreatitis risk; high total cholesterol requires intervention; abnormal ratios aid cardiovascular risk stratification
    • Iron Studies: Low iron with high TIBC indicates iron deficiency anemia; low transferrin saturation (<20%) confirms iron deficiency; high iron with high saturation suggests hemochromatosis or secondary iron overload; normal values exclude iron disorders
    • Thyroid Profile: Elevated TSH with low T4 indicates primary hypothyroidism; low TSH with elevated T3/T4 indicates hyperthyroidism; isolated elevated TSH suggests subclinical hypothyroidism; normal values exclude thyroid dysfunction
    • HbA1c and eAG: HbA1c >6.5% on two occasions confirms diabetes diagnosis; 5.7-6.4% indicates prediabetes requiring intervention; eAG provides estimated average glucose corresponding to HbA1c percentage for treatment goals
    • ESR: Elevated ESR (>20 mm/hr in women, >15 mm/hr in men) indicates systemic inflammation, infection, malignancy, or autoimmune disease; markedly elevated ESR (>100 mm/hr) warrants urgent investigation; normal ESR doesn't exclude disease
    • hs-CRP: Elevated hs-CRP (>3.0 mg/L) indicates inflammation and increases cardiovascular risk; helps stratify intermediate-risk patients; levels >10 mg/L suggest acute infection or severe inflammation
    • Vitamin B12: Low B12 (<200 pg/mL) causes pernicious anemia, neuropathy, and cognitive dysfunction; 200-400 pg/mL borderline requiring symptom correlation; deficiency may occur with normal serum B12 (check methylmalonic acid)
    • 25-OH Vitamin D: <20 ng/mL indicates deficiency causing rickets, osteomalacia, and impaired immunity; 20-29 ng/mL is insufficient; >30 ng/mL is sufficient for most; >100 ng/mL may indicate excess supplementation
    • Urine Complete: Proteinuria (>trace) suggests kidney disease or orthostatic proteinuria; glycosuria indicates diabetes or renal threshold abnormality; hematuria requires urologic evaluation; nitrites/leukocyte esterase positive suggests urinary tract infection
    • Rheumatoid Factor: Positive RF (>10 IU/mL) seen in rheumatoid arthritis, Sjögren's syndrome, and some infections; 70% sensitive for RA but occurs in other conditions; negative RF doesn't exclude seronegative RA
    • Total IgE: Elevated (>100 IU/mL) in allergic conditions, atopic dermatitis, asthma, and parasitic infections; very high levels (>1000 IU/mL) suggest IgE-mediated disease or hyperimmunoglobulinemia
    • Amylase and Lipase: Markedly elevated (>3x upper limit) strongly suggests acute pancreatitis; mild elevations require clinical correlation; lipase remains elevated longer than amylase; may be falsely elevated in macroamylasemia
    • Phosphorus and Calcium: Low calcium with high phosphorus and elevated PTH indicates secondary hyperparathyroidism; high calcium with low phosphorus suggests hyperparathyroidism; abnormalities affect bone health and cardiac function
    • CEA (Carcinoembryonic Antigen): Elevated CEA (>5 ng/mL) may indicate colorectal cancer, lung cancer, gastric cancer, or smoking; mild elevation without malignancy suggests benign disease; used for baseline before cancer treatment and surveillance
  • Associated Organs
    • Sugar (Glucose): Primarily evaluates pancreatic beta-cell function and insulin sensitivity; indirectly assesses brain, kidneys, and liver glucose metabolism; abnormalities increase risk of microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular disease (MI, stroke)
    • CBC: Evaluates bone marrow function, immune system, and blood-forming capacity; hemoglobin abnormalities affect all organs through oxygen delivery; abnormal WBC indicates infection risk or hematologic malignancy; platelet abnormalities cause bleeding or thrombotic complications
    • Liver Function Tests: Directly evaluate hepatic synthetic function, detoxification, and metabolism; abnormalities indicate hepatocellular injury, cholestasis, or cirrhosis; associated conditions include viral hepatitis, alcoholic liver disease, autoimmune hepatitis, and hepatic fibrosis
    • Kidney Profile: Evaluates glomerular filtration, tubular function, and electrolyte balance; detects acute kidney injury, chronic kidney disease, and complications of diabetes and hypertension; associated conditions include glomerulonephritis, pyelonephritis, nephrolithiasis, and renal artery stenosis
    • Lipid Profile: Evaluates cardiovascular risk through hepatic cholesterol synthesis and lipoprotein metabolism; abnormalities increase risk of atherosclerotic cardiovascular disease, myocardial infarction, stroke, and peripheral arterial disease; associated with metabolic syndrome and diabetes
    • Iron Studies: Evaluate bone marrow hematopoiesis, gut absorption, and liver storage; iron deficiency affects all organs through anemia; iron overload causes cirrhosis, cardiomyopathy, diabetes, and arthropathy; associated conditions include GI bleeding and hereditary hemochromatosis
    • Thyroid Profile: Evaluates thyroid gland function and metabolism regulation; affects all organs through thyroid hormone effects on metabolic rate, heart rate, temperature regulation, and bone metabolism; associated conditions include Graves' disease, Hashimoto's thyroiditis, and thyroid malignancy
    • HbA1c and eAG: Reflects pancreatic beta-cell function, insulin sensitivity, and glucose homeostasis; predicts risk of microvascular complications (eyes, kidneys, nerves) and macrovascular disease; used to guide therapy and assess long-term glycemic control
    • ESR: Non-specific marker of systemic inflammation; elevated in infections (tuberculosis, endocarditis), malignancies, autoimmune diseases (rheumatoid arthritis, lupus), vasculitis, and temporal arteritis; used for disease activity monitoring
    • hs-CRP: Marker of systemic inflammation produced by liver; indicates acute coronary syndrome, infection, autoimmune disease, and chronic inflammatory conditions; elevated levels increase cardiovascular and cerebrovascular risk
    • Vitamin B12: Essential for neurologic function, DNA synthesis, and red blood cell formation; affects brain, nerves, bone marrow, and GI tract; deficiency causes pernicious anemia, paresthesias, ataxia, and cognitive dysfunction; caused by malabsorption or pernicious anemia
    • 25-OH Vitamin D: Critical for calcium absorption in GI tract, bone mineralization, and immune function; deficiency affects skeletal system (rickets, osteomalacia, osteoporosis), immune system (increased infections), and endocrine system; associated with secondary hyperparathyroidism
    • Urine Complete: Evaluates kidneys, urinary tract, and systemic disease; detects proteinuria (kidney disease), glycosuria (diabetes), hematuria (urologic malignancy, stones), infection (UTI, pyelonephritis), and casts (glomerulonephritis); abnormalities require further investigation
    • Rheumatoid Factor: Screens for autoimmune rheumatologic disease; elevated in rheumatoid arthritis, Sjögren's syndrome, systemic lupus erythematosus, and other autoimmune conditions; affects joints (synovitis), lungs (pulmonary fibrosis), heart (pericarditis), and blood vessels
    • Total IgE: Evaluates immune system response and allergic sensitization; elevated in allergic/atopic diseases affecting lungs (asthma), skin (atopic dermatitis), nose (allergic rhinitis), and GI tract; also elevated in parasitic infections and immunodeficiency
    • Amylase and Lipase: Directly evaluate pancreatic enzyme production; elevated in acute pancreatitis affecting pancreas, GI tract, and peritoneum; may be elevated in other conditions affecting salivary glands (mumps), intestines (peritonitis), or kidney dysfunction
    • Phosphorus and Calcium: Essential for bone metabolism, cardiac conduction, muscle contraction, and nerve transmission; abnormalities affect skeletal system (osteoporosis, osteomalacia), heart (arrhythmias), muscles (tetany), and kidneys (secondary hyperparathyroidism)
    • CEA: Tumor marker for screening and surveillance in malignancy; elevated in colorectal cancer (60-90% advanced cases), lung cancer, gastric cancer, pancreatic cancer, and other adenocarcinomas; non-specific, requiring clinical correlation and imaging confirmation
  • Follow-up Tests
    • Sugar (Glucose): If elevated, obtain oral glucose tolerance test (OGTT) for diabetes classification; repeat HbA1c in 3 months to confirm diagnosis; continuous glucose monitoring for insulin-dependent diabetes; assess renal function and albuminuria for complication screening
    • CBC: If hemoglobin low, obtain iron studies, B12/folate levels, reticulocyte count, and peripheral smear; if WBC elevated, obtain differential count and blood smear; if platelets low, obtain coagulation profile; repeat CBC in 2-4 weeks to assess trend
    • Liver Function Tests: If abnormal, obtain viral hepatitis serology (hepatitis A, B, C antibodies), autoimmune markers (ANA, anti-mitochondrial antibodies), acetaminophen and alcohol levels; perform abdominal ultrasound for liver echotexture; consider liver biopsy if fibrosis suspected
    • Kidney Profile: If creatinine elevated or eGFR <60, repeat in 1-2 weeks to assess acute vs chronic; obtain urine albumin-to-creatinine ratio; ultrasound kidneys to assess size and echogenicity; if potassium elevated, obtain ECG; check PTH and calcium-phosphorus if eGFR <45
    • Lipid Profile: If abnormal, repeat fasting lipid panel; add Lp(a) and apoB if elevated cardiovascular risk; obtain inflammatory markers (hs-CRP); assess for metabolic syndrome criteria; initiate statin therapy if indicated and repeat lipids in 6-8 weeks
    • Iron Studies: If iron deficient, evaluate for GI blood loss with fecal occult blood testing and upper/lower endoscopy if indicated; assess dietary intake and absorption; repeat iron studies after 8-12 weeks of iron supplementation; check ferritin periodically
    • Thyroid Profile: If TSH abnormal, repeat with free T4 and free T3; obtain TPO antibodies and thyroglobulin antibodies for autoimmune thyroiditis; thyroid ultrasound if nodule suspected; repeat TSH after 6-8 weeks of levothyroxine initiation to adjust dose
    • HbA1c and eAG: If elevated, refer to endocrinologist for intensive glucose management; repeat HbA1c every 3 months until stable, then annually; obtain home glucose monitoring logs; screen for complications with urine microalbumin and fundoscopic exam every year
    • ESR: If elevated, investigate underlying cause with imaging studies (chest X-ray, abdominal ultrasound), infection workup (blood cultures, tuberculosis testing), or malignancy screening; repeat ESR every 4-8 weeks to monitor disease activity or treatment response
    • hs-CRP: If elevated, assess cardiovascular risk factors and initiate preventive therapy; obtain lipid panel, blood pressure; consider aspirin prophylaxis if intermediate-high risk; repeat hs-CRP after 3 months of lifestyle modification to assess response
    • Vitamin B12: If low, check folate, methylmalonic acid, and homocysteine levels; assess for pernicious anemia with Schilling test or intrinsic factor antibodies; evaluate for malabsorption with endoscopy if indicated; initiate B12 supplementation and repeat levels in 8-12 weeks
    • 25-OH Vitamin D: If deficient, initiate vitamin D3 supplementation 1000-4000 IU daily; repeat level in 8-12 weeks; monitor calcium and phosphorus; obtain bone density scan (DXA) if osteoporosis risk factors present; check PTH if calcium abnormal
    • Urine Complete: If abnormal findings, obtain 24-hour urine protein quantification; urine microscopy for casts; urine culture if infection suspected; ultrasound kidneys if hematuria; renal biopsy if proteinuria >3.5 g/day or active sediment; repeat urinalysis annually
    • Rheumatoid Factor: If positive, obtain anti-CCP antibodies (higher specificity for RA); perform ESR and CRP; obtain imaging (X-ray hands/feet); refer to rheumatologist for evaluation and disease-modifying therapy; repeat RF annually to monitor disease activity
    • Total IgE: If elevated, perform specific IgE testing for allergens implicated by history; skin prick testing to confirm allergen sensitization; assess for parasitic infections in appropriate epidemiologic setting; refer to allergist if significant elevation
    • Amylase and Lipase: If elevated, perform imaging (abdominal ultrasound or CT) to visualize pancreas; obtain liver function tests; check triglycerides (>500 mg/dL causes pancreatitis); assess medication history (valproic acid, azathioprine); repeat lipase every 24-48 hours during acute illness
    • Phosphorus and Calcium: If abnormal, obtain PTH, vitamin D, and magnesium levels; assess renal function and acid-base status; perform imaging (bone density scan) if osteoporosis suspected; repeat levels 1-2 weeks after intervention; monitor for clinical signs of hypo/hypercalcemia
    • CEA: If elevated, perform colonoscopy to evaluate for colorectal cancer; obtain chest CT to screen for lung cancer; abdominal/pelvic imaging based on clinical suspicion; consider endoscopy and gastric imaging if history suggests gastric malignancy; repeat CEA every 3-6 months for surveillance
  • Fasting Required?
    • YES - This test package REQUIRES a fasting period of 8-12 hours (preferably 10-12 hours) prior to blood collection for accurate and reliable results
    • Fasting requirements: No food or beverages (except water) for the specified 8-12 hour period; fasting should ideally begin at 10:00 PM for morning collection at 8:00 AM
    • Water: Unlimited plain water is permitted during fasting period; water does not affect test results and aids sample collection
    • Avoid during fasting period: No coffee, tea, milk, juice, soda, or any caloric beverages; no gum chewing, mints, or candy; no smoking for at least 30 minutes before collection
    • Medications: Continue essential medications (heart, blood pressure, anti-seizure medications) as prescribed unless specifically instructed otherwise by physician; take medications with small sip of water if necessary
    • Medications to discuss with physician: Lipid-lowering drugs may be held for 2 weeks prior to collection if restarting therapy; antibiotics should be completed before testing if possible; hormone replacement therapy may affect test results
    • Collection timing: Early morning (6:00 AM - 9:00 AM) preferred for fasting specimen; collection becomes increasingly non-fasting as hours progress from fasting start
    • Previous day preparation: Maintain normal diet the day prior to fasting; avoid excessive food, alcohol, and fatty foods evening before test; avoid strenuous exercise 24 hours before collection
    • Stress management: Ensure adequate sleep (7-9 hours) the night before testing; avoid stressful situations as stress elevates glucose and inflammatory markers; minimize physical activity morning of collection
    • Why fasting required: Fasting lipids increase accuracy of lipid panel interpretation for cardiovascular risk assessment; fasting glucose provides standardized measurement; fasting ensures reproducibility and comparability with reference ranges
    • Consequences of non-fasting: Non-fasting specimens may show falsely elevated triglycerides, VLDL, and glucose; lipid ratios become unreliable; glucose interpretation becomes impossible; results become non-interpretable and test may require repeat
    • Special populations: Diabetic patients on insulin should still fast but should be prepared to treat hypoglycemia if symptoms occur; elderly should arrange transportation as fasting may affect balance; children should be coached on fasting expectations
    • Urine sample: Collect mid-stream morning urine sample (first void after waking); this represents overnight urine concentration, providing optimal specimen for urinalysis with maximum cellular and molecular yield
    • What NOT to do: Do not reschedule test to non-fasting time; do not drink energy drinks or vitamin-enriched water; do not take new supplements morning of test; do not delay collection if fasting requirements met

How our test process works!

customers
customers